Fig. 3From: Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort studyCumulative incidence rates according to soluble neprilysin level. a All-cause death and (b) the major cardiovascular eventsBack to article page